COMMUNIQUÉS West-GlobeNewswire

EssilorLuxottica: Résultat du paiement du dividende en actions et constatation de l’augmentation de capital correspondante
03/06/2025
Résultat du paiement du dividende en actions et constatation de l’augmentation de capital correspondante Paris, France (3 juin 2025 - 16h30) – L’Assemblée générale annuelle d’EssilorLuxottica a décidé de donner aux [...]
Evaxion receives grant funding to design new polio vaccine
03/06/2025
Evaxion awarded a grant from the Gates Foundation Grant funds research aimed at ultimately eradicating polio, a highly infectious viral disease Evaxion will apply its leading AI-Immunology™ platform to identify and [...]
PharmAla Completes Shipment of LaNeo™ MDMA to Yale University, Provides Investor Update
03/06/2025
TORONTO, June 03, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of [...]
Dogwood Therapeutics to Present at Sidoti Small-Cap Virtual Conference
03/06/2025
ATLANTA, June 03, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (“Dogwood” or the “Company”), a development-stage biotechnology company developing new medicines to treat pain and fatigue-related [...]
Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform
03/06/2025
Expanded IP Portfolio Enhances Data Harmonization and Predictive Analytics Capabilities for High-Growth Biomedical Markets LOS ANGELES, June 03, 2025 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB) , a clinical-stage [...]
Bioxytran’s Groundbreaking Stroke & Alzheimer’s Tech Gains Validation That Measures Oxygenation Uptake During Strokes
03/06/2025
Mongolian Gerbil Research Unlocks Critical Insights for Ischemic Stroke and Neurodegenerative Disease Treatments BOSTON, MASSACHUSETTS, June 03, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a [...]
Trethera Secures New License, Strengthening TRE-515 Intellectual Property Portfolio and Extending Market Exclusivity to 2045
03/06/2025
LOS ANGELES, June 03, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, today announced it [...]
Visory Health Survey Reveals Critical Gap in Prescription Savings for Uninsured Spanish Speakers
03/06/2025
Nearly half of uninsured Spanish speakers are unfamiliar with prescription discount cards – a gap that’s putting affordable medications out of reach for millions ESTERO, Fla., June 03, 2025 (GLOBE NEWSWIRE) -- Visory [...]
Connect Biopharma Announces Two Oral Presentations at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress
03/06/2025
SAN DIEGO, June 03, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a clinical-stage biopharmaceutical company focused on transforming acute and chronic [...]
Myriad Genetics Announces Early Access to the FirstGene Multiple Prenatal Screen
03/06/2025
Screening test provides prenatal risk assessment for common genetic conditions in one blood draw without the need for paternal testing Early access via large-scale clinical study to establish the validity and utility of [...]
BioAge Expands APJ Agonist Pipeline with Oral Small-Molecule and Long-Acting Biologic Candidates
03/06/2025
Company enters option agreement with JiKang Therapeutics to in-license novel APJ agonist antibody New composition of matter IP filed for chemically distinct, orally active, and highly potent small molecule APJ agonists [...]
H1 Acquires Veda to Solve Healthcare’s Provider Data Challenge and Power Better Care
03/06/2025
Acquisition equips health plans with next-generation provider data management, enabling improved access to care and better health outcomes NEW YORK, June 03, 2025 (GLOBE NEWSWIRE) -- H1 , on a mission to connect the [...]
Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences’ Patent Portfolio and IP Value
03/06/2025
Patent covers estimation of measures of heart function using an ECG, which are critical in the diagnosis and early detection of heart disease Southlake, TX, June 03, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: [...]
BON Announces Share Repurchase Program for up to US$1.0 Million
03/06/2025
XI’AN, China, June 03, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a leading bio-ingredient solution provider in the natural, health and personal care industry, today [...]
THE FUTURE OF FOOD IS MADE IN CANADA: The Homegrown Innovation Challenge Launches $20M Scaling Phase Grant to Support Domestic Food Production
03/06/2025
TORONTO, June 03, 2025 (GLOBE NEWSWIRE) -- It has never been more important for Canada to have a secure and sustainable supply of food. Building on its longstanding commitment to improving the well-being of Canadians, [...]
L’AVENIR DE LA PRODUCTION ALIMENTAIRE EST FAIT AU CANADA : Le Défi Cultiver l’innovation d’ici offre une subvention de 20 M$ dans le cadre de sa phase de mise à l’échelle pour soutenir la production alimentaire nationale
03/06/2025
TORONTO, 03 juin 2025 (GLOBE NEWSWIRE) -- Il est plus essentiel que jamais d’assurer au Canada un approvisionnement alimentaire sécuritaire et durable. Poursuivant son engagement de longue date envers l’amélioration du [...]
Babesiosis Incidence in U.S. 10x Higher Than CDC Estimates, According to Insurance Claims Study Commissioned by 60 Degrees Pharmaceuticals
03/06/2025
25,000 U.S. adults per year claim reimbursement for medical costs associated with babesiosis v. CDC estimates of 2,000 A full 45 percent of persistent babesiosis cases include chronic fatigue Healthcare providers [...]
Titan Pharmaceuticals Announces Filing of Registration Statement for Proposed Business Combination with TalenTec Sdn. Bhd.
03/06/2025
NEW YORK, June 03, 2025 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) announced today the filing by Black Titan Corporation with the U.S. Securities and Exchange Commission (“ [...]
NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate Secretary
03/06/2025
EDEN PRAIRIE, Minn., June 03, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and [...]

Pages